-
December 19, 2006 Lupin gets tentative US FDA approval for Trandolapril
-
December 7, 2006 Lupin gets DCGI approval to conduct Phase III clinical trials for Migraine NCE
-
October 19, 2006 Lupin FY 2006-07 Q2 Net Profit up by 29% at Rs.583 mn
-
September 30, 2006 Lupin and Dafra decide not to pursue their MoU
-
September 28, 2006 Lupin gets US FDA approval for Lisinopril-HCTZ Tablets
-
September 16, 2006 Mr. Edward R. Roberts joins Lupin Board
-
September 14, 2006 Lupin gets US FDA approval for Ceftriaxone 10gm vials
-
July 26, 2006 Lupin receives DCGI approval to conduct Phase II Clinical Trials for Psoriasis NCE
-
July 25, 2006 Lupin FY 2006-07 Q1 Sales up by 33% at Rs.4.9 bn
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications